Highlights – 1st Quarter 2010
Total revenues increase 13% to EUR 2.1 billion
Profit after tax more than triples to EUR 195 million
Free cash flow improves to EUR 195 from EUR 164 million
Rebif® sales +17% to EUR 429 million
Erbitux® sales +19% to EUR 192 million
Liquid Crystals revenues up 82%, guidance improved
Guidance raised: Operating result by +30% to +40%
Millipore planned acquisition announced
Total revenues
Operating result
by quarterEUR million
Total revenues by quarter (bar chart)

SERVICES

DOWNLOADS

Download PDF (2.7 MB) Download XLS (0.1 MB)

ANNUAL REPORT 2009

Read the Annual Report online
 
Imprint, © Merck KGaA, Darmstadt, Germany, Last Update 2010/04/28